Clinical Trial Update: SORAVE - Sorafenib and Everolimus in Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sorafenib and everolimus in solid tumors, including non-small cell lung cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Afinitor (everolimus)
• Nexavar (Sorafenib)

Snippet

Sponsor: University of Cologne | Conditions: Unspecified Adult Solid Tumor, Protocol Specific, Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED